Lista articolelor în limba engleza
Afisarea articolelor: 1-2(2)
2019
| 1. | Efficacy and safety of delamanid in combination with an optimised background regimen for treatment of multidrug-resistant tuberculosis: a multicentre, randomised, double-blind, placebo-controlled, parallel group phase 3 trial . The Lancet Respiratory Medicine. 2019, nr. , 259-249. ISSN 2213-2600. (Cat. ) |
2018
| 2. | Revising the definition of extensively drug-resistant tuberculosis . The Lancet Respiratory Medicine. 2018, nr. , 895-893. ISSN 2213-2600. (Cat. ) |
    |
1-2 of 2
